BioCentury
ARTICLE | Clinical News

Cytotect regulatory update

January 15, 2007 8:00 AM UTC

FDA granted Orphan Drug designation for Cytotect to treat cytomegalovirus (CMV) infections in pregnant women. The hyperimmunoglobulin also has Orphan Drug designation in Europe. ...